Cargando…
Adverse Events of DOACs in Children
Venous thromboembolism (VTE) has an increasing rate of significance in pediatric patients. The currently standardized anticoagulants (unfractionated heparin, low molecular weight heparin and vitamin K antagonists) and their dose regimens were not comprehensively trialed in pediatric patients. Recent...
Autores principales: | Bosch, Alessandra, Albisetti, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289097/ https://www.ncbi.nlm.nih.gov/pubmed/35859947 http://dx.doi.org/10.3389/fped.2022.932085 |
Ejemplares similares
-
Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
por: Bosch, Alessandra, et al.
Publicado: (2020) -
A novel nomogram for predicting respiratory adverse events during transport after interventional cardiac catheterization in children
por: Tong, Chaoyang, et al.
Publicado: (2022) -
Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS)
por: Kong, Wenqiang, et al.
Publicado: (2023) -
Adverse events in the treatment of spinal muscular atrophy in children and adolescents with nusinersen: A systematic review and meta-analysis
por: Zhong, Zhi-Juan, et al.
Publicado: (2023) -
Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)